Skip to main content
Fig. 7 | BMC Medical Genomics

Fig. 7

From: Identification of breast cancer subgroups and immune characterization based on glutamine metabolism-related genes

Fig. 7

Predicted results of hub genes in BC LR and HR subgroups in CellMiner (IC50 refers to the drug concentration required to reduce the number of surviving cells by half after drug treatment. The lower the IC50, the more sensitive to the drug, and the stronger the inhibitory effect on tumor cells. The correlation coefficient Cor between 0.1–0.3 indicates weak correlation, 0.3–0.5 indicates moderate correlation, and 0.5-1.0 indicates strong correlation.)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us